Market Pulse

MDxHealth Q3 2026: Double Miss on EPS and Revenue Signals Deepening Commercial Trouble

MDxHealth missed Q3 2026 EPS by $0.07 and revenue by $5.52M (~20%), with operating losses accelerating 102% over nine months — a company-specific bearish signal with minimal broader market spillover.

VolatileRegulation EnforcementCrypto

Crypto State-Sponsored Hacks1h ago

DOJ Seizes $1.2B From North Korea's Binance Hack — BNB Leverage Risk Map & Cross-Market Fallout

The DOJ has court-authorized seizure of $1.2B from North Korea's $6B+ Binance hack — with BNB down 3.70% at $656.30, high-leverage long positions face liquidation risk from any renewed fund-movement headlines, while ~$3.3B in stolen crypto remains potentially in circulation.

BearishRegulation EnforcementCrypto

DOJ Moves to Seize $1.2B From Binance Hack — BNB Leverage Risk Map & Cross-Market Fallout

DOJ court-authorized seizure of $1.2B from the $6B+ Binance hack removes near-term forced-sell pressure but injects persistent legal headline risk — BNB's -3.82% drop to $655.50 creates elevated liquidation risk for leveraged longs, while crypto-cybersecurity equities see a relative tailwind.

NeuroPace Q3 2026: Revenue Miss and Guidance Cut Signal Commercial Execution Risk

NeuroPace's $4.06M revenue miss is secondary to an ~$9M full-year guidance cut driven by account disruption — a commercial execution problem, not a demand collapse, but bearish for NPCE near-term.

Sutro Biopharma (STRO) Q3 2026 Miss: Revenue Slides, Cash Burn Remains Elevated

Sutro Biopharma missed Q3 revenue and EPS estimates, with collaboration-dependent income falling to $9.1M; the pipeline outlook and cash runway are the real trade drivers.

BearishHackCrypto

Crypto State-Sponsored Hacks1h ago

North Korea's FaceStealer Stole $400M in Crypto via Deepfake Calls — Leverage Risk Map for BNB & Crypto Exchange Stocks

North Korean hackers stole $400M in crypto via AI deepfake video calls; BNB is down 4.67% to $653.80 — leveraged longs face liquidation risk below $647 at 100x, while cybersecurity equities (CRWD, PANW) stand to benefit from accelerating enterprise security demand.

Bitcoin (BTC) is trending today

Trade Bitcoin with up to 2000x leverage on CoinUnited.io

Also trending: BNB · CRWV · DXY

Trade BTC/USD →

VolatileEarnings BeatStocks

AMAT

Applied Materials Q4 FY2026 Beats on Revenue & EPS, Guides Above Forecasts — AMAT CFD Leverage Impact & Semi Sector Read-Through

Applied Materials beat Q4 FY2026 estimates on revenue ($10.41B, +53% YoY) and EPS ($4.16 non-GAAP) while guiding Q1 FY2027 above consensus — but AMAT CFD is down 3.82% in a sell-the-news move, creating a leveraged-entry timing decision around key levels of $375.35 support and $397.60 resistance.

BullishEarnings BeatStocks

CSCO

Cisco Beats & Raises FY27 Guidance: AI Revenue to More Than Double as Hyperscaler Orders Accelerate

Cisco raised FY27 AI revenue guidance to $9B (2x FY26) on strong hyperscaler orders; CSCO trades at $102.19 (+1.49%), creating defined leverage entry/exit levels for CFD traders while sending a broad bullish signal across AI-infrastructure and semiconductor indices.

AI Infrastructure Capital Reallocation WaveAI Revenue Monetization & Chip Demand Surge2h ago

BullishEarnings BeatStocks

CBRS

Cerebras Surges 18% on Q3 Beat & Microsoft Deal: Leverage Traps, Margin Upside, and AI Chip Contagion Mapped

Cerebras beat Q3 revenue by 7.5%, guided Q4 ~21% above consensus, and signed Microsoft as a customer — CBRS is up 12.77% to $113.90, but high-leverage longs near the session high face liquidation risk on any reversal before the regular session open.

AI-Cloud Enterprise Embedding WaveAI Revenue Monetization & Chip Demand Surge2h ago

SoundThinking Q3 2026: $0.61 EPS Miss and 12% Revenue Shortfall Flag Contract-Renewal Risk

SoundThinking missed Q3 EPS by $0.61 and revenue by ~12%, citing non-renewed contracts; with no guidance and no earnings call due to a pending acquisition, SSTI faces amplified uncertainty and near-term bearish pressure.

United States Antimony (UAMY) Q3 Miss: Price Collapse Overwhelms Volume Gains

UAMY missed Q3 revenue by $6.59M as a 28% drop in antimony prices wiped out a 20% volume increase — the pricing collapse, not production, is the problem.

Nu Holdings Q3 2026: Revenue Miss of $120M Despite 40% Growth — What It Means for NU Stock

Nu Holdings missed Q3 2026 revenue by $120M despite 40% year-over-year growth; EPS was in-line, but the top-line shortfall has pushed NU down 3.97% — forward guidance and credit quality are now the key catalysts.

M&A Acquisition Wave4h ago

BullishAcquisitionStocks

CorMedix Acquires Heron Therapeutics Assets for $145M Cash Plus Stock, Targeting $45M–$60M in Annual Synergies

CorMedix is acquiring Heron Therapeutics' commercial assets for $145M cash plus stock, targeting $45M–$60M in synergies and $125M–$150M in 2027 revenue contribution — a marketed-asset deal that makes CRMD an accretion story and HRTX a pure arb play pending Q1 2027 close.

BullishPartnershipStocks

DPC Holdings Locks In Fifth 10-Year IGT Partnership With $1.28B Revenue Target by 2027

DPC Holdings secured a fifth 10-year IGT partnership with ~$100M+ annual revenue contribution by 2032 and guided 2027 revenue to $1.28B midpoint — a structurally bullish, company-specific industrial catalyst with limited cross-market read-through.

Strategic Corporate Partnerships4h ago

VolatileHackCrypto